Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$1.45M Sell
28,775
-1,051
-4% -$51.5K 0.4% 73
2015
Q4
$1.5M Buy
29,826
+753
+3% +$38K 0.41% 72
2015
Q3
$1.37M Sell
29,073
-2,156
-7% -$115K 0.42% 75
2015
Q2
$1.7M Sell
31,229
-247
-0.8% -$13.9K 0.49% 68
2015
Q1
$1.73M Sell
31,476
-342
-1% -$19.4K 0.45% 68
2014
Q4
$1.72M Buy
31,818
+1,096
+4% +$61.1K 0.41% 69
2014
Q3
$1.74M Buy
30,722
+409
+1% +$23K 0.57% 54
2014
Q2
$1.67M Sell
30,313
-16
-0.1% -$873 0.54% 60
2014
Q1
$1.65M Buy
+30,329
New +$1.57M 0.56% 59

Other funds holding MRK

HHG & Company's MRK Position: Q1 2016 in Review

HHG & Company reduced its Merck (MRK) stake by 3.5% in Q1 2016, selling an estimated $51.5K and leaving 28,775 shares worth $1.45M. The position accounts for 0.4% of the portfolio, ranked #73.

HHG & Company first reported a position in MRK in Q1 2014 and has held it in 9 quarters since. The position peaked at $1.74M in Q3 2014. 1,745 funds tracked by Wall St. Rank hold MRK as of Q1 2016.

  • HHG & Company held 28,775 shares of Merck worth $1.45M as of Q1 2016.
  • HHG & Company sold 1,051 Merck shares in Q1 2016, an estimated $51.5K.
  • Merck made up 0.4% of HHG & Company's portfolio in Q1 2016, its #73 holding.
  • HHG & Company first reported a position in Merck in Q1 2014 and has held it in 9 quarters since.
  • HHG & Company's Merck position peaked at $1.74M in Q3 2014.
  • 1,745 funds tracked by Wall St. Rank held Merck as of Q1 2016.

Based on HHG & Company's 13F filing for Q1 2016, filed 20 Apr 2016.